PR Pro's Cancer Drug Trial Petition Goes Viral
Until recently, Mikaela Knapp worked as an account director at San Francisco’s SparkPR. For the past six months, she’s been receiving treatment for an aggressive form of kidney cancer. She is 25 years old.
Her husband, her co-workers and her colleagues in the industry hope that new drugs currently being developed by the major pharmaceutical companies will help her fight her disease—and they’ve gone social with their appeal to Merck and other manufacturers.
Knapp’s husband Keith’s Change.org petition, created to convince Merck, Genentech and/or Bristol-Meyers Squibb to include her in a “compassionate use” clinical trial of these new drugs as soon as possible, is on its way to meeting its goal.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in